GBIM OTC
GlobeImmune, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -85.7%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$6M
+8.2% ▲
5Y CAGR: +9.7%
Gross Profit
$4M
+291.1% ▲
5Y CAGR: -1.3%
Operating Income
-$3M
+52.5% ▲
Net Income
-$3M
+86.3% ▲
EPS (Diluted)
$-0.48
+93.1% ▲
EBITDA
-$3M
+78.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $5M | $15M | $23M | $6M | $6M |
| YoY Growth | +25.6% | +186.6% | +53.8% | -73.5% | +8.2% |
| Cost of Revenue | $0 | $10K | $9M | $5M | $3M |
| Gross Profit | $5M | $15M | $13M | $974K | $4M |
| Gross Margin | 100.0% | 99.9% | 59.9% | 16.3% | 59.0% |
| R&D Expenses | $12M | $12M | $11M | $7M | $4M |
| SG&A Expenses | $5M | $6M | $3M | $4M | $5M |
| Operating Expenses | $18M | $19M | $15M | $12M | $9M |
| Operating Income | -$13M | -$4M | $8M | -$6M | -$3M |
| Operating Margin | -246.6% | -27.1% | 34.1% | -97.5% | -42.8% |
| Interest Expense | $0 | $0 | $0 | $4M | $0 |
| Income Before Tax | -$14M | -$2M | $10M | -$16M | -$3M |
| Tax Expense | $1M | $0 | $116K | $4M | $0 |
| Net Income | -$15M | -$2M | $9M | -$20M | -$3M |
| Net Margin | -290.9% | -13.8% | 42.1% | -337.8% | -42.8% |
| EPS (Diluted) | $-155.37 | $-21.07 | $-35.64 | $-6.91 | $-0.48 |
| EBITDA | -$13M | -$1M | $8M | -$12M | -$3M |
| Shares Outstanding | 95622 | 95622 | 95622 | 3M | 6M |